National Stock Number
6505-00-108-4965
National Stock Number (NSN) 6505-00-108-4965, or NIIN 001084965, (atropine injection) was assigned January 1, 1963 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.
There are no manufacturer part numbers associated to this NSN.
This part number has not been procured by the US Government in over 5 years.
Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Dec 01, 2020, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. The Government physically does not have in its possession sufficient, accurate, or legible data to purchase this part from other than current source(s). (NOTE: This code is applicable only to parts under immediate buy requirements and only as long as the deficiency is under review for resolution and appropriate recoding.) Valid AMCs: 1, 2, 3, 4 and 5.
This NSN is assigned to Item Name Code (INC) 09296. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505001084965 does not contain precious metals.
This NSN is associated to Schedule B 2933997000: drugs primarily affecting the central nervous system, not elsewhere specified or included. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325411: medicinal and botanical manufacturing.
This information was last updated on Jul 01, 2025.